List of Tables
Table 1. Blood Vessels Embolic Agents Market Trends
Table 2. Blood Vessels Embolic Agents Market Drivers & Opportunity
Table 3. Blood Vessels Embolic Agents Market Challenges
Table 4. Blood Vessels Embolic Agents Market Restraints
Table 5. Global Blood Vessels Embolic Agents Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Blood Vessels Embolic Agents Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Blood Vessels Embolic Agents Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Blood Vessels Embolic Agents Product Type
Table 9. Key Companies Time to Begin Mass Production of Blood Vessels Embolic Agents
Table 10. Global Blood Vessels Embolic Agents Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Vessels Embolic Agents as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Blood Vessels Embolic Agents Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Blood Vessels Embolic Agents Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Blood Vessels Embolic Agents Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Blood Vessels Embolic Agents Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Blood Vessels Embolic Agents Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Blood Vessels Embolic Agents Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Blood Vessels Embolic Agents Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Blood Vessels Embolic Agents Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Blood Vessels Embolic Agents Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Blood Vessels Embolic Agents Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Blood Vessels Embolic Agents Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Blood Vessels Embolic Agents Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Blood Vessels Embolic Agents Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Blood Vessels Embolic Agents Sales Value by Region (2019-2024) & (%)
Table 27. Global Blood Vessels Embolic Agents Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Blood Vessels Embolic Agents Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Blood Vessels Embolic Agents Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Blood Vessels Embolic Agents Sales Value, (2025-2030) & (US$ Million)
Table 31. Abbott Basic Information List
Table 32. Abbott Description and Business Overview
Table 33. Abbott Blood Vessels Embolic Agents Products, Services and Solutions
Table 34. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of Abbott (2019-2024)
Table 35. Abbott Recent Developments
Table 36. Boston Scientific Corporation Basic Information List
Table 37. Boston Scientific Corporation Description and Business Overview
Table 38. Boston Scientific Corporation Blood Vessels Embolic Agents Products, Services and Solutions
Table 39. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of Boston Scientific Corporation (2019-2024)
Table 40. Boston Scientific Corporation Recent Developments
Table 41. Cook Medical LLC Basic Information List
Table 42. Cook Medical LLC Description and Business Overview
Table 43. Cook Medical LLC Blood Vessels Embolic Agents Products, Services and Solutions
Table 44. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of Cook Medical LLC (2019-2024)
Table 45. Cook Medical LLC Recent Developments
Table 46. Johnson & Johnson Basic Information List
Table 47. Johnson & Johnson Description and Business Overview
Table 48. Johnson & Johnson Blood Vessels Embolic Agents Products, Services and Solutions
Table 49. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of Johnson & Johnson (2019-2024)
Table 50. Johnson & Johnson Recent Developments
Table 51. Medtronic Basic Information List
Table 52. Medtronic Description and Business Overview
Table 53. Medtronic Blood Vessels Embolic Agents Products, Services and Solutions
Table 54. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of Medtronic (2019-2024)
Table 55. Medtronic Recent Developments
Table 56. Acandis GmbH Basic Information List
Table 57. Acandis GmbH Description and Business Overview
Table 58. Acandis GmbH Blood Vessels Embolic Agents Products, Services and Solutions
Table 59. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of Acandis GmbH (2019-2024)
Table 60. Acandis GmbH Recent Developments
Table 61. SSEM Mthembu Medical (Pty) Ltd Basic Information List
Table 62. SSEM Mthembu Medical (Pty) Ltd Description and Business Overview
Table 63. SSEM Mthembu Medical (Pty) Ltd Blood Vessels Embolic Agents Products, Services and Solutions
Table 64. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of SSEM Mthembu Medical (Pty) Ltd (2019-2024)
Table 65. SSEM Mthembu Medical (Pty) Ltd Recent Developments
Table 66. Balt USA LLC Basic Information List
Table 67. Balt USA LLC Description and Business Overview
Table 68. Balt USA LLC Blood Vessels Embolic Agents Products, Services and Solutions
Table 69. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of Balt USA LLC (2019-2024)
Table 70. Balt USA LLC Recent Developments
Table 71. Stryker Basic Information List
Table 72. Stryker Description and Business Overview
Table 73. Stryker Blood Vessels Embolic Agents Products, Services and Solutions
Table 74. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of Stryker (2019-2024)
Table 75. Stryker Recent Developments
Table 76. Guerbet LLC Basic Information List
Table 77. Guerbet LLC Description and Business Overview
Table 78. Guerbet LLC Blood Vessels Embolic Agents Products, Services and Solutions
Table 79. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of Guerbet LLC (2019-2024)
Table 80. Guerbet LLC Recent Developments
Table 81. Terumo Corporation Basic Information List
Table 82. Terumo Corporation Description and Business Overview
Table 83. Terumo Corporation Blood Vessels Embolic Agents Products, Services and Solutions
Table 84. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of Terumo Corporation (2019-2024)
Table 85. Terumo Corporation Recent Developments
Table 86. Penumbra Basic Information List
Table 87. Penumbra Description and Business Overview
Table 88. Penumbra Blood Vessels Embolic Agents Products, Services and Solutions
Table 89. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of Penumbra (2019-2024)
Table 90. Penumbra Recent Developments
Table 91. Grandpharma (Sirtex) Basic Information List
Table 92. Grandpharma (Sirtex) Description and Business Overview
Table 93. Grandpharma (Sirtex) Blood Vessels Embolic Agents Products, Services and Solutions
Table 94. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of Grandpharma (Sirtex) (2019-2024)
Table 95. Grandpharma (Sirtex) Recent Developments
Table 96. Merit Medical Basic Information List
Table 97. Merit Medical Description and Business Overview
Table 98. Merit Medical Blood Vessels Embolic Agents Products, Services and Solutions
Table 99. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of Merit Medical (2019-2024)
Table 100. Merit Medical Recent Developments
Table 101. Siemens Healthineers (Varian) Basic Information List
Table 102. Siemens Healthineers (Varian) Description and Business Overview
Table 103. Siemens Healthineers (Varian) Blood Vessels Embolic Agents Products, Services and Solutions
Table 104. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of Siemens Healthineers (Varian) (2019-2024)
Table 105. Siemens Healthineers (Varian) Recent Developments
Table 106. Jiangsu Hengrui Medicine Basic Information List
Table 107. Jiangsu Hengrui Medicine Description and Business Overview
Table 108. Jiangsu Hengrui Medicine Blood Vessels Embolic Agents Products, Services and Solutions
Table 109. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of Jiangsu Hengrui Medicine (2019-2024)
Table 110. Jiangsu Hengrui Medicine Recent Developments
Table 111. Kaneka Basic Information List
Table 112. Kaneka Description and Business Overview
Table 113. Kaneka Blood Vessels Embolic Agents Products, Services and Solutions
Table 114. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of Kaneka (2019-2024)
Table 115. Kaneka Recent Developments
Table 116. Meril Life Sciences Basic Information List
Table 117. Meril Life Sciences Description and Business Overview
Table 118. Meril Life Sciences Blood Vessels Embolic Agents Products, Services and Solutions
Table 119. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of Meril Life Sciences (2019-2024)
Table 120. Meril Life Sciences Recent Developments
Table 121. Peijia Medical Basic Information List
Table 122. Peijia Medical Description and Business Overview
Table 123. Peijia Medical Blood Vessels Embolic Agents Products, Services and Solutions
Table 124. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of Peijia Medical (2019-2024)
Table 125. Peijia Medical Recent Developments
Table 126. Wallaby Medical Basic Information List
Table 127. Wallaby Medical Description and Business Overview
Table 128. Wallaby Medical Blood Vessels Embolic Agents Products, Services and Solutions
Table 129. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of Wallaby Medical (2019-2024)
Table 130. Wallaby Medical Recent Developments
Table 131. MicroPort Scientific Corporation Basic Information List
Table 132. MicroPort Scientific Corporation Description and Business Overview
Table 133. MicroPort Scientific Corporation Blood Vessels Embolic Agents Products, Services and Solutions
Table 134. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of MicroPort Scientific Corporation (2019-2024)
Table 135. MicroPort Scientific Corporation Recent Developments
Table 136. Weihai Visee Medical Devices Basic Information List
Table 137. Weihai Visee Medical Devices Description and Business Overview
Table 138. Weihai Visee Medical Devices Blood Vessels Embolic Agents Products, Services and Solutions
Table 139. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of Weihai Visee Medical Devices (2019-2024)
Table 140. Weihai Visee Medical Devices Recent Developments
Table 141. Beijing Taijieweiye Technology Basic Information List
Table 142. Beijing Taijieweiye Technology Description and Business Overview
Table 143. Beijing Taijieweiye Technology Blood Vessels Embolic Agents Products, Services and Solutions
Table 144. Revenue (US$ Million) in Blood Vessels Embolic Agents Business of Beijing Taijieweiye Technology (2019-2024)
Table 145. Beijing Taijieweiye Technology Recent Developments
Table 146. Key Raw Materials Lists
Table 147. Raw Materials Key Suppliers Lists
Table 148. Blood Vessels Embolic Agents Downstream Customers
Table 149. Blood Vessels Embolic Agents Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
Table 153. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Blood Vessels Embolic Agents Product Picture
Figure 2. Global Blood Vessels Embolic Agents Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Blood Vessels Embolic Agents Sales Value (2019-2030) & (US$ Million)
Figure 4. Blood Vessels Embolic Agents Report Years Considered
Figure 5. Global Blood Vessels Embolic Agents Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Blood Vessels Embolic Agents Revenue in 2023
Figure 7. Blood Vessels Embolic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Microsphere Picture
Figure 9. Liquid Embolics Agents Picture
Figure 10. Embolic Coils Picture
Figure 11. Embolic Plug Systems Picture
Figure 12. Detachable Balloons Picture
Figure 13. Others Picture
Figure 14. Global Blood Vessels Embolic Agents Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Blood Vessels Embolic Agents Sales Value Market Share by Type, 2023 & 2030
Figure 16. Product Picture of Hospital & Clinic
Figure 17. Product Picture of Ambulatory Surgical Center
Figure 18. Product Picture of Others
Figure 19. Global Blood Vessels Embolic Agents Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Blood Vessels Embolic Agents Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Blood Vessels Embolic Agents Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Blood Vessels Embolic Agents Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Blood Vessels Embolic Agents Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Blood Vessels Embolic Agents Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Blood Vessels Embolic Agents Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Blood Vessels Embolic Agents Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Blood Vessels Embolic Agents Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Blood Vessels Embolic Agents Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Blood Vessels Embolic Agents Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Blood Vessels Embolic Agents Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Blood Vessels Embolic Agents Sales Value (%), (2019-2030)
Figure 32. United States Blood Vessels Embolic Agents Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Blood Vessels Embolic Agents Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Blood Vessels Embolic Agents Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Blood Vessels Embolic Agents Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Blood Vessels Embolic Agents Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Blood Vessels Embolic Agents Sales Value by Application (%), 2023 VS 2030
Figure 38. China Blood Vessels Embolic Agents Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Blood Vessels Embolic Agents Sales Value by Type (%), 2023 VS 2030
Figure 40. China Blood Vessels Embolic Agents Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Blood Vessels Embolic Agents Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Blood Vessels Embolic Agents Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Blood Vessels Embolic Agents Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Blood Vessels Embolic Agents Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Blood Vessels Embolic Agents Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Blood Vessels Embolic Agents Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Blood Vessels Embolic Agents Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Blood Vessels Embolic Agents Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Blood Vessels Embolic Agents Sales Value by Application (%), 2023 VS 2030
Figure 50. India Blood Vessels Embolic Agents Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Blood Vessels Embolic Agents Sales Value by Type (%), 2023 VS 2030
Figure 52. India Blood Vessels Embolic Agents Sales Value by Application (%), 2023 VS 2030
Figure 53. Blood Vessels Embolic Agents Industrial Chain
Figure 54. Blood Vessels Embolic Agents Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
